Results 81 to 90 of about 9,808 (274)

Combination therapy for hypertension [PDF]

open access: yes, 2003
published_or_final_versio
Cheung, BMY, Kumana, CR, Lau, CP
core  

The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes [PDF]

open access: yes, 2001
Objective: The purpose of this study was to investigate the properties of the slow component of the delayed rectifier potassium current (I-Ks) in myocytes isolated from undiseased human left ventricles.
Bogáts, Gábor   +8 more
core   +1 more source

Resistant Hypertension: Questions and Contemporary Answers

open access: yesРациональная фармакотерапия в кардиологии, 2019
The review presents the important problem of resistant hypertension. Its real prevalence is unknown. According to population studies and metaanalyzes of clinical studies, the prevalence of this most severe form of hypertension reaches 12-15% in the ...
V. I. Podzolkov   +2 more
doaj   +1 more source

Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions [PDF]

open access: yes, 2008
Hypertension is an alarming public health problem among Chinese. The present study evaluated the prescribing patterns, discontinuation and switching profiles of antihypertensive agents and their associated factors in one Hong Kong Chinese population ...
A Fretheim   +14 more
core   +1 more source

PJA2 Suppresses Colorectal Cancer Progression by Controlling HDAC2 Degradation and Stability

open access: yesAdvanced Science, Volume 12, Issue 13, April 3, 2025.
PJA2, an E3 ubiquitin‐protein ligase, actively restrains colorectal cancer (CRC) progression. It targets histone deacetylase 2 (HDAC2) for degradation, which in turn activates the interferon‐induced protein with tetratricopeptide repeats (IFIT) family, effectively hindering tumor growth and promoting apoptosis.
Zhihao Chen   +13 more
wiley   +1 more source

COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AFTER THE STROKE

open access: yesРациональная фармакотерапия в кардиологии, 2016
Aim. To evaluate influence of the combined therapy with ACE inhibitor (perindopril), diuretic (indapamide) and dihydropyridine calcium channel blocker (amlodipine) on ambulatory blood pressure (BP) monitoring indices and heart rate variability in ...
O. A. Ageenkova   +2 more
doaj   +1 more source

Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data [PDF]

open access: yes, 2008
<b>Objectives</b> Increasing use is being made of routinely collected electronic patient data in health services research. The aim of the present study was to evaluate the potential usefulness of a comprehensive database used routinely in the
A McCormack   +47 more
core   +4 more sources

PERINDOPRIL: THE POSSIBILITY OF ANTIHYPERTENSIVE AND RENOPROTECTIVE THERAPY

open access: yesРациональная фармакотерапия в кардиологии, 2016
Blood pressure (BP) control in patients with chronic kidney disease is one of the most pressing problems in modern cardiology and nephrology. Perindopril therapy reduces cardiovascular risk in patients with arterial hypertension and nephropathy, provides
O. V. Dralova, M. L. Maksimov
doaj   +1 more source

Asian Pacific Society of Nephrology Clinical Practice Guideline on Diabetic Kidney Disease—2025 Update

open access: yes
Nephrology, Volume 30, Issue S2, Page 3-56, July 2025.
Adrian Liew   +10 more
wiley   +1 more source

IEFFICACY OF INDAPAMIDE AND VALSARTAN COMBINED THERAPY PATIENTS WITH ARTERIAL HYPERTENSION AND METABOLIC DISORDERS

open access: yesЕвразийский Кардиологический Журнал, 2014
Aim of the study: to study antihypertensive and organ-protective efficacy of indapamide and valsartan combined therapy hypertensive patients with high cardiovascular risk and metabolic disorders.
G. A. Khamidullaeva   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy